Abstract

Diabetic Foot Ulcers (DFUs) pose a formidable challenge in the management of diabetes, frequently leading to severe complications and compromising the overall health and quality of life for affected individuals. As the prevalence of diabetes continues to rise globally, the exploration and development of pharmacotherapeutic interventions for DFUs have become an imperative area of research. This abstract provides an overview of recent advancements in pharmacotherapy, focusing on innovative approaches aimed at accelerating wound healing, preventing infections, and ultimately improving outcomes for patients with diabetic foot ulcers. Topical agents, including growth factors, cytokines, and antimicrobial agents, have shown promise in promoting wound healing and preventing infections. Additionally, advanced dressings and topical formulations are being designed to enhance the local microenvironment, optimizing conditions for tissue repair.